Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Bliss GVS Pharma Ltd.

  • NSE: BLISSGVS

  • BSE: 506197

  • Q
  • V
  • T
  • Expensive Rocket
46.10/100

Quality Score

Medium Financial Strength
20.50/100

Valuation Score

Expensive Valuation
71.00/100

Technical Score

Technically Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

67.55

MFI is mid-range

50Day SMA Rs

139.55 Rs

Price above SMA 139.55

Quality score

46.10

Medium Financial Strength

30Day SMA Rs

151.63 Rs

Price above SMA 151.63

Broker Covering stock

0.00

0 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Momentum score

71.00

Technically Bullish

Price to Book Ratio

2.76

Above industry Median

Broker 1Year total

0.00

0 Broker 1Year total

TTM PE Ratio

23.16

Above industry Median

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

75.66

RSI Overbought

Net Profit Qtr Cr

16.65 Cr

Above industry Median

AVG Broker Target

-100.00 %

No targets last year

Operating Revenues Qtr Cr

129.55 Cr

Above industry Median

MACD

4.96

MACD above Signal and Center

Valuation score

20.50

Expensive Valuation

MACD Signal Line

4.68

MACD above Signal and Center

FII holding %

23.96 %

FII holding decreased by 0.2%.

Promoter holding %

41.60 %

No change in Promoter holding

MF holding %

0.01 %

No change in MF holding

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

119.50 Rs

Price above SMA 119.5

Institutions holding %

26.93 %

Institutions holding decreased by 0.2%.

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

121.51 Rs

Price above SMA 121.51

NSE BLISSGVS
176.35
  • 170.20 Close
  • 171.50 Open
  • 11.60 Lk Volume
Today Low/High
Low 169.65
High 181.10
52 Week Low/High
13-03-2020 81.25
01-10-2020 181.10

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Bliss GVS Pharma Ltd. 176.35 23.16 1818.99 0.28 16.65 0 129.55 -38.76 2.75
Sun Pharmaceutical Industries Ltd. 506.9 475.82 121620.51 0.78 -2429.81 0 7585.25 -9.43 2.47
Dr. Reddy's Laboratories Ltd. 5112.05 44.79 84962.27 0.48 586.9 0 4426.5 14.72 5.45
Divi's Laboratories Ltd. 3064.9 50.97 81357.77 0.52 492.06 0 1730.47 48.8 11.12
Cipla Ltd. 773 37.82 62323.12 0.51 571.42 0 4346.16 8.95 3.88
Aurobindo Pharma Ltd. 818.65 15.95 47964.7 0.51 792.68 0 5924.78 8.81 2.85
Torrent Pharmaceuticals Ltd. 2817.2 42.19 47678.29 1.13 321 0 2056 1.68 9.88
Lupin Ltd. 1027.84 -99.66 46571.88 0.58 108.14 0 3527.86 -20.16 3.7